Incyte Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Incyte Corporation is an American multinational pharmaceutical company. The company operates manufacturing, research and development into biopharmaceutical medical solutions in areas like autoimmunity, inflammation and oncology.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Incyte Corporation has a net positive value on humanity, primarily due to Healthcare R&D ($15.6 B), Pharmaceuticals ($2.0 B), and Economic Value ($722.4 M). Positive value from Healthcare R&D and Pharmaceuticals is linked to an estimate of 340,000 additional years lived by people worldwide. Incyte Corporation can increase its Humankind Value by addressing impacts related to Biofuel Production (-$397.5 M) and Greenhouse Gases (-$118.1 M). Healthcare R&D, Pharmaceuticals, Economic Value, and Greenhouse Gases are attached to Incyte Corporation as a result of its direct business activities. Biofuel Production is mostly or entirely a result of supply-chain relationships.